Cloning and expression of feline colony stimulating factor receptor (CSF-1R) and analysis of the species specificity of stimulation by colony stimulating factor-1 (CSF-1) and interleukin-34 (IL-34)

Cytokine

Volumn 61, Issue 2, 2013, Pages 630-638

  Gow, Deborah J ^a   Garceau, Valerie ^a   Pridans, Clare ^a   Gow, Adam G ^a   Simpson, Kerry E ^a   Gunn Moore, Danielle ^a   Hume, David A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Ba F3; Bone marrow; Macrophage; Renal; Species specificity

Indexed keywords

COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR RECEPTOR; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 34; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CAT; CELL CULTURE; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MOLECULAR CLONING; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA EXTRACTION; SWINE;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CATS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; INTERLEUKINS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHAGOCYTOSIS; RECEPTORS, COLONY-STIMULATING FACTOR; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; SUS SCROFA;

FELIDAE; RODENTIA; SUIDAE;

EID: 84873169643     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.11.014     Document Type: Article

References (67)

1. Hume D.A., Macdonald K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012, 119:1810-1820.
2. Gow D.J., Garceau V., Kapetanovic R., Sester D.P., Fici G.J., Shelly J.A., et al. Cloning and Expression of Porcine Colony Stimulating Factor-1 (CSF-1) and Colony Stimulating Factor-1 Receptor (CSF-1R) and analysis of the species specificity of stimulation by CSF-1 and Interleukin 34. Cytokine 2012, http://dx.doi.org/10.1016/j.cyto.2012.08.008.
3. Chitu V., Stanley E.R. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 2006, 18:39-48.
4. Bonifer C., Hume D.A. The transcriptional regulation of the colony-stimulating factor 1 receptor (csf1r) gene during hematopoiesis. Front. Biosci. 2008, 13:549-560.
5. Sherr C.J., Rettenmier C.W., Sacca R., Roussel M.F., Look A.T., Stanley E.R. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985, 41:665-676.
6. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320:807-811.
7. Garceau V., Smith J., Paton I.R., Davey M., Fares M.A., Sester D.P., et al. Pivotal advance: avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products. J Leukocyte Biol 2010, 45:45.
8. Wei S., Nandi S., Chitu V., Yeung Y.G., Yu W., Huang M., et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J Leukocyte Biol 2010, 88:495-505.
9. Droin N., Solary E. Editorial: CSF1R, CSF-1, and IL-34, a "menage a trois" conserved across vertebrates. J Leukocyte Biol 2010, 87:745-747.
10. Chihara T., Suzu S., Hassan R., Chutiwitoonchai N., Hiyoshi M., Motoyoshi K., et al. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ 2010, 17:1917-1927.
11. Hume D.A., Pavli P., Donahue R.E., Fidler I.J. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J Immunol 1988, 141:3405-3409.
12. Das S.K., Stanley E.R., Guilbert L.J., Forman L.W. Human colony-stimulating factor (CSF-1) radioimmunoassay: resolution of three subclasses of human colony-stimulating factors. Blood 1981, 58:630-641.
13. Das S.K., Stanley E.R., Guilbert L.J., Forman L.W. Discrimination of a colony stimulating factor subclass by a specific receptor on a macrophage cell line. J Cell Physiol 1980, 104:359-366.
14. Woolford J., McAuliffe A., Rohrschneider L.R. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 1988, 55:965-977.
15. Yoshihara K., Inumaru S., Hirota Y., Momotani E. Cloning and sequencing of cDNA encoding bovine macrophage colony-stimulating factor (bM-CSF) and expression of recombinant bM-CSF using baculovirus. Vet Immunol Immunopathol 1998, 63:381-391.
16. Abrams K., Yunusov M.Y., Slichter S., Moore P., Nelp W.B., Burstein S.A., et al. Recombinant human macrophage colony-stimulating factor-induced thrombocytopenia in dogs. Br J Haematol 2003, 121:614-622.
17. Stanley E.R., Guilbert L.J. Methods for the purification, assay, characterization and target cell binding of a Colony Stimulating Factor (CSF-1). J Immunol Methods 1981, 42:253-284.
18. Francey T., Jungi T.W., Rey O., Peterhans E. Culture of ovine bone marrow-derived macrophages and evidence for serum factors distinct from M-CSF contributing to their propagation in vitro. J Leukocyte Biol 1992, 51:525-534.
19. Hume D.A. Macrophages as APC and the dendritic cell myth. J Immunol 2008, 181:5829-5835.
20. Mabbott N.A., Kenneth Baillie J., Hume D.A., Freeman T.C. Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations. Immunobiology 2010, 215:724-736.
21. Lacey D.C., Achuthan A., Fleetwood A.J., Dinh H., Roiniotis J., Scholz G.M., et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol 2012, 188:5752-5765.
22. Bienzle D., Reggeti F., Clark M.E., Chow C. Immunophenotype and functional properties of feline dendritic cells derived from blood and bone marrow. Vet Immunol Immunopathol 2003, 96:19-30.
23. Sprague W.S., Pope M., Hoover E.A. Culture and comparison of feline myeloid dendritic cells vs macrophages. J Comp Pathol 2005, 133:136-145.
24. Vermeulen B.L., Gleich S.E., Dedeurwaerder A., Olyslaegers D.A., Desmarets L.M., Dewerchin H.L., et al. In vitro assessment of the feline cell-mediated immune response against feline panleukopeniavirus, calicivirus and felid herpesvirus 1 using 5-bromo-2'-deoxyuridine labeling. Vet Immunol Immunopathol 2012, 146:177-184.
25. Nemunaitis J., Shannon-Dorcy K., Appelbaum F.R., Meyers J., Owens A., Day R., et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1993, 82:1422-1427.
26. Wei S., Lightwood D., Ladyman H., Cross S., Neale H., Griffiths M., et al. Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody. Immunobiology 2005, 210:109-119.
27. Martinez M., Ono N., Planutiene M., Planutis K., Nelson E.L., Holcombe R.F. Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int 2012, 12:2.
28. Vinuesa E., Hotter G., Jung M., Herrero-Fresneda I., Torras J., Sola A. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. J Pathol 2008, 214:104-113.
29. Nakamura T., Abu-Dahab R., Menger M.D., Schafer U., Vollmar B., Wada H., et al. Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant 2005, 24:38-45.
30. Leor J., Rozen L., Zuloff-Shani A., Feinberg M.S., Amsalem Y., Barbash I.M., et al. Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation 2006, 114:100-194.
31. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005, 115:56-65.
32. Ricardo S.D., van Goor H., Eddy A.A. Macrophage diversity in renal injury and repair. J Clin Invest 2008, 118:3522-3530.
33. Alikhan M.A., Jones C.V., Williams T.M., Beckhouse A.G., Fletcher A.L., Kett M.M., et al. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am J Pathol 2011, 179:1243-1256.
34. Fitzgerald K.T. Lily toxicity in the cat. Top Companion Anim Med 2010, 25:213-217.
35. Gowan R.A., Lingard A.E., Johnston L., Stansen W., Brown S.A., Malik R. Retrospective case-control study of the effects of long-term dosing with meloxicam on renal function in aged cats with degenerative joint disease. J Feline Med Surg 2011, 13:752-761.
36. Ross L. Acute kidney injury in dogs and cats. Vet Clin N Am Small Anim Pract 2011, 41:1-14.
37. Bischoff K., Rumbeiha W.K. Pet food recalls and pet food contaminants in small animals. Vet Clin N Am Small Anim Pract 2012, 42:237-250.
38. O'Keefe D.A., Schaeffer D.J. Hematologic toxicosis associated with doxorubicin administration in cats. J Vet Int Med 1992, 6:276-282.
39. O'Keefe D.A., Sisson D.D., Gelberg H.B., Schaeffer D.J., Krawiec D.R. Systemic toxicity associated with doxorubicin administration in cats. J Vet Int Med 1993, 7:309-317.
40. Reiman R.A., Mauldin G.E., Neal Mauldin G. A comparison of toxicity of two dosing schemes for doxorubicin in the cat. J Feline Med Surg 2008, 10:324-331.
41. Worwag S., Langston C.E. Acute intrinsic renal failure in cats: 32 cases (1997-2004). J Am Vet Med Assoc 2008, 232:728-732.
42. Awad A.S., Rouse M., Huang L., Vergis A.L., Reutershan J., Cathro H.P., et al. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 2009, 75:689-698.
43. Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988, 18:97-104.
44. Tagoh H., Himes R., Clarke D., Leenen P.J., Riggs A.D., Hume D., et al. Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells. Genes Dev 2002, 16:1721-1737.
45. Penning L.C., Vrieling H.E., Brinkhof B., Riemers F.M., Rothuizen J., Rutteman G.R., et al. A validation of 10 feline reference genes for gene expression measurements in snap-frozen tissues. Vet Immunol Immunopathol 2007, 120:212-222.
46. Ma X., Lin W.Y., Chen Y., Stawicki S., Mukhyala K., Wu Y., et al. Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure 2012, 20:676-687.
47. Liu H., Leo C., Chen X., Wong B.R., Williams L.T., Lin H., et al. The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. Biochim Biophys Acta 2012, 1824:938-945.
48. Chen X., Liu H., Focia P.J., Shim A.H., He X. Structure of macrophage colony stimulating factor bound to FMS: diverse signaling assemblies of class III receptor tyrosine kinases. Proc Natl Acad Sci USA 2008.
49. Irvine K.M., Andrews M.R., Fernandez-Rojo M.A., Schroder K., Burns C.J., Su S., et al. Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages. J Leukocyte Biol 2008, 34:45.
50. Kapetanovic R., Fairbairn L., Beraldi D., Sester D.P., Archibald A.L., Tuggle C.K., et al. Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J Immunol 2012, 89:90.
51. Lania L., Griffiths M., Cooke B., Ito Y., Fried M. Untransformed rat cells containing free and integrated DNA of a polyoma nontransforming (Hr-t) mutant. Cell 1979, 18:793-802.
52. Hume D.A., Gordon S. Optimal conditions for proliferation of bone marrow-derived mouse macrophages in culture: the roles of CSF-1, serum, Ca2+, and adherence. J Cell Physiol 1983, 117:189-194.
53. Hume D.A., Allan W., Golder J., Stephens R.W., Doe W.F., Warren H.S. Preparation and characterization of human bone marrow-derived macrophages. J Leukocyte Biol 1985, 38:541-552.
54. Hume D.A., Gordon S. The correlation between plasminogen activator activity and thymidine incorporation in mouse bone marrow-derived macrophages. Opposing actions of colony-stimulating factor, phorbol myristate acetate, dexamethasone and prostaglandin E. Exp Cell Res 1984, 150:347-355.
55. Schroder K., Irvine K.M., Taylor M.S., Bokil N.J., Le Cao K.A., Masterman K.A., et al. Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci USA 2012, 109:E944-53.
56. Daniel S.L., Legendre A.M., Moore R.N., Rouse B.T. Isolation and functional studies on feline bone marrow derived macrophages. Vet Immunol Immunopathol 1993, 36:107-122.
57. Choi S., Park M., Kim J., Hwang S., Park S., Lee Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 2009, 18:521-529.
58. Guillot P.V., Cook H.T., Pusey C.D., Fisk N.M., Harten S., Moss J., et al. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol 2008, 214:627-636.
59. Quimby J.M., Webb T.L., Gibbons D.S., Dow S.W. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. J Feline Med Surg 2011, 13:418-426.
60. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
61. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
62. Webb T.L., Quimby J.M., Dow S.W. In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells. J Feline Med Surg 2012, 14:165-168.
63. Kilroy G.E., Foster S.J., Wu X., Ruiz J., Sherwood S., Heifetz A., et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007, 212:702-709.
64. Majumdar M.K., Thiede M.A., Haynesworth S.E., Bruder S.P., Gerson S.L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000, 9:841-848.
65. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998, 176:57-66.
66. Mayer P., Werner F.J., Lam C., Besemer J. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs. Exp Hematol 1990, 18:1026-1033.
67. Arai M., Darman J., Lewis A., Yamamoto J.K. The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats. Vet Immunol Immunopathol 2000, 77:71-92.